- Filed
- Feb 20, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 20, 2024 | 67.47M sh |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $2.62K |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $35.15K |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $316.81K |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $295.13K |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $316.81K |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $295.13K |
| Current Assets | Q2 2024 · Dec 31, 2023 | $2.62K |
| Current Assets | Q2 2024 · Jun 30, 2023 | $43.13K |
| Total Assets | Q2 2024 · Dec 31, 2023 | $2.62K |
| Total Assets | Q2 2024 · Jun 30, 2023 | $43.13K |
| Operating Income | Q2 2024 · Dec 31, 2023 | $11.39M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 61.92M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 61.49M sh |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | −$47.91K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$202.32K |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | −$160.6K |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | −$117.61K |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.00 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $66.87K |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $125.93K |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $0 |
| Net Income | Q2 2024 · Dec 31, 2022 | −$93.59K |
| Net Income | Q2 2024 · Dec 31, 2022 | −$188.47K |
| Net Income | Q2 2024 · Sep 30, 2022 | −$94.87K |